Switch from Immediate-release Pramipexole to Extended-release Pramipexole: The Safety and Efficacy Characteristics of Sixty-eight Patients


KUZU M., ÖZER İ. Ş., TEZCAN S., HERDİ O., AKBOSTANCI M. C.

Turkish Journal Of Neurology, vol.22, no.3, pp.114-116, 2016 (ESCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 22 Issue: 3
  • Publication Date: 2016
  • Doi Number: 10.4274/tnd.48751
  • Journal Name: Turkish Journal Of Neurology
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.114-116
  • Keywords: Parkinson disease, dopamine agonist, extended-release pramipexole, RANDOMIZED CONTROLLED-TRIAL, PARKINSONS-DISEASE, AGONIST
  • Lokman Hekim University Affiliated: No

Abstract

Objective: To evaluate the safety and efficacy of switching from immediate-release pramipexole (pex) to extended-release pramipexole (pex-ER).